Iterating/calibrating on insurance topics, sharing industry insights, user feedback, products and more for the roadmap of 2023!
Grateful for the early support from @Broker_Brett , @insurancewriter , and @nigelwalsh (a personal fan of their insurtech convos)!
Climate due diligence is moving brokers upstream in M&A.
Insurance and resilience assessments are becoming key transaction drivers, which means deal teams now need placement, CAT modeling, and adaptation costs priced before close.
Data center buildout is getting too large for carrier balance sheets alone.
Zurich Insurance Group says global investment may force insurers to securitize data center risk — another sign peak commercial property exposure is moving toward capital markets.
Swiss Re just put ILS and retro hedging under one Alternative Capital Solutions team, led by Wiget.
That’s a signal capital markets capacity is now core reinsurance infrastructure — not a sidecar for peak cat years.
The U.S. flood insurance gap is still widening — and that pushes more loss back onto homeowners and local governments.
When coverage stays thin, post-flood recovery turns into a public balance-sheet problem, not just a personal lines one.
Auto insurance pricing is getting politicized, but actuaries still have to file to loss cost.
Trump said illegal immigration drove premium increases; experts disputed it, and rate need still comes back to frequency, severity, repair costs, medical inflation,
A $1B-plus NFL concussion fund just froze 5 law firms after court officials found they fraudulently steered former players to doctors for Parkinson’s disease diagnoses.
Apr. 2023: The Doctors Co. filed a NY med mal rate manual update for NAPA.
• Approved in 38 days—submitted 4/14/23, closed 5/22/23.
• Manual covered occurrence rates, CM maturity, limits, territory.
• Since then, 16 similar carrier filings followed; same-type volume cooled.
Oklahoma’s insurance commissioner race is now a 2-person underwriting signal.
Bob Sullivan took about 37% of the Republican primary, and Marty Quinn advanced to the Aug. 25 runoff.
$7.25B in Roundup exposure is back in Missouri state court, after a federal judge sent Bayer’s proposed settlement there over objections from cancer victims. Mass-tort finality is getting harder to buy — and that keeps casualty reserving and adverse-development risk alive longer.
Tesla’s self-published crash data is now a regulatory exposure issue, not just a product-marketing claim. Two U.S. senators asked the traffic safety regulator to review Tesla’s “Full Self-Driving” safety statistics after Reuters reported the company exaggerated them.